IFRX (InflaRx NV) Bozor qiymatining balans qiymatiga nisbati
InflaRx N.V. (IFRX) uchun xavflar kamyob kasalliklar uchun dori vositalarining tasdiqlanishiga bog'liqlik va sug'urta kompaniyalari terapiya xarajatlarini qoplashni rad etish ehtimoli bilan bog'liq bo'lib, bu ko'rsatkichni 1.41 darajasida ushlab turadi. Ushbu hamroh narxlar grafigi strategiyasi C5a inhibitorini bozorga olib chiqish va yangi tibbiy ko'rsatmalarni aniqlashga asoslangan aktivning dinamikasini namoyish etadi. Biznes daromadlari hukumat ko'magiga va virusli infeksiyalar uchun vilobelimabni joriy qilish istiqbollariga asoslangan.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_IFRX_-_InflaRx-N.V._-_Market-Capitalization-to-Net-Assets "IFRX InflaRx Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
InflaRx N.V. (IFRX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:InflaRx NV - IFRX
InflaRx N.V. hozirgi vaqtda yallig'lanishga qarshi vositalarni joriy etishni kengaytirmoqda, bu esa yuqori reklama xarajatlari tufayli vaqtincha marjalarni cheklaydi. Narxning buki qiymatiga nisbatini tahlil qilish orqali investor kompaniyaning sof kapitalidan yuqori bo'lgan bozor premiumini baholaydi. Ushbu ko'rsatkich bozor qiymati va buki baholash o'rtasidagi farq orqali aktivlarni boshqarish samaradorligini o'lchaydi. Ushbu nisbatning oshishi bozorning kelajakdagi daromadlariga bo'lgan ishonchini bildiradi; biroq, operatsion o'sishning yetishmasligi aksiyalarning keskin qadrsizlanishiga olib kelishi mumkin.
Asosiy raqobatchilar
Kapitallashuvning sof aktivlarga nisbati argenx SE|BNTX (biontech.de) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|Bozor kapitallashuvining balans qiymatiga nisbati RIGL (Rigel Pharmaceuticals Inc)|ANAB: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Astria Therapeutics|engene.com (ENGN) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RAPT Therapeutics RAPT|Sof aktivlarga nisbatan bozor kapitallashuvi JBIO|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|Bozor qiymatining balans qiymatiga nisbati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati TLSA (Tiziana Life Sciences)|cabalettabio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ventyx Biosciences, Inc. (VTYX)|Theratechnologies, Inc. (THTX) - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Avalo Therapeutics Inc.|Kapitallashuvning balans qiymatiga nisbati Eledon Pharmaceuticals, Inc|AGEN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati CLYM|Bozor qiymatining balans qiymatiga nisbati Zura Bio ZURA|Kapitallashuvning balans qiymatiga nisbati aTyr Pharma Inc ATYR|Kapitallashuvning sof aktivlarga nisbati ADAG|IMA - Balans qiymatiga nisbatan bozor kapitallashuvi|STTK - Kapitallashuvning sof aktivlarga nisbati|Equillium, Inc. (EQ) - Bozor qiymatining balans qiymatiga nisbati|connectbiopharm.com - Kapitallashuvning sof aktivlarga nisbati|Immunic (IMUX) - Balans qiymatiga nisbatan bozor kapitallashuvi|ATRA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi X4 Pharmaceuticals, Inc|ACET - Bozor kapitallashuvining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CELU (celularity.com)|Bozor qiymatining balans qiymatiga nisbati INmune Bio|BRNS - Balans qiymatiga nisbatan bozor qiymati|Kezar Life Sciences, Inc (KZR) - Kapitallashuvning sof aktivlarga nisbati|SABS: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Akari Therapeutics (AKTX)|Enlivex Therapeutics Ltd. (ENLV) - Sof aktivlarga nisbatan bozor kapitallashuvi|QTTB - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GeoVax Labs|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio Corporation)|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc.|xtlbio.com - Balans qiymatiga nisbatan bozor qiymati|BOLT: Bozor qiymatining balans qiymatiga nisbati|HCWB - Kapitallashuvning sof aktivlarga nisbati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati aimimmuno.com|ADTX - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati gribio.com|XRTX (XORTX Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HIND (Vyome Holdings Inc.)|Revelation Bio - Bozor qiymatining balans qiymatiga nisbati|Indaptus Corp - Kapitallashuvning sof aktivlarga nisbati|SCNI: Bozor qiymatining balans qiymatiga nisbati|CalciMedica, Inc. (CALI) - Kapitallashuvning sof aktivlarga nisbati|AFMD: Kapitallashuvning sof aktivlarga nisbati|ALLK (Allakos) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc. (HOOK)|Kapitallashuvning balans qiymatiga nisbati IGM Bio|iTeos Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi